Direct measurements of membrane potential and membrane resistance of human red cells

Yazar: Lassen, U. V., Sten-Knudsen, O.
Baskı/Yayın Bilgisi 1968

P16.23 A COMPARISON OF 18F-FET AND 18F-FLT MICROPET FOR THE ASSESSMENT OF ANTI-VEGF EFFICACY IN AN ORTHOTOPIC MURINE MODEL OF GLIOBLASTOMA

Yazar: Nedergaard, M.K., Michaelsen, S.R., Poulsen, H.S., Lassen, U., Stockhausen, M., Kjær, A.
Baskı/Yayın Bilgisi 2014

Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression

Yazar: Lassen, U N, Østerlind, K, Hirsch, F R, Bergman, B, Dombernowsky, P, Hansen, H H
Baskı/Yayın Bilgisi 1999

A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours

Yazar: Lassen, U, Nielsen, D L, Sørensen, M, Winstedt, L, Niskanen, T, Stenberg, Y, Pakola, S, Stassen, J-M, Glazer, S
Baskı/Yayın Bilgisi 2012

P17.91 CLINICAL VARIABLES SERVE AS PREDICTIVE FACTORS IN A MODEL FOR CLINICAL RESPONSE TO BEVACIZUMAB IN RECURRENT GLIOBLASTOMA MULTIFORME: AN OBSERVATIONAL STUDY OF A COHORT OF CO...

Yazar: Urup, T., Grunnet, K., Christensen, I.J., Michaelsen, S.R., Broholm, H., Stockhausen, M.T., Lassen, U., Poulsen, H.S.
Baskı/Yayın Bilgisi 2014

P08.06 Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

Yazar: Urup, T., Staunstrup, L., Michaelsen, S., Vitting-Seerup, K., Bennedbæk, M., Toft, A., Broholm, H., Hamerlik, P., Poulsen, H., Lassen, U.
Yayımlandı Neuro Oncol (2016)

A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with s...

Yazar: Lassen, U, Molife, L R, Sorensen, M, Engelholm, S-A, Vidal, L, Sinha, R, Penson, R T, Buhl-Jensen, P, Crowley, E, Tjornelund, J, Knoblauch, P, de Bono, J S
Baskı/Yayın Bilgisi 2010

A Comparison of Endoscopic Ultrasound Guided Biopsy and Positron Emission Tomography with Integrated Computed Tomography in Lung Cancer Staging

Yazar: Larsen, S.S., Vilmann, P., Krasnik, K., Dirksen, Asger, Clementsen, P., Skov, Birgit G., Jacobsen, Grete Krag, Lassen, U., Eigtved, Annika, Berthelsen, Anne Kiil, Mortensen, J., Hoejgaard, Liselotte
Baskı/Yayın Bilgisi 2009

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma

Yazar: Even, C., Lassen, U., Merchan, J., Le Tourneau, C., Soria, J-C, Ferte, C., Ricci, F., Diener, J. T., Yuen, E., Smith, C., Oakley, G. J., Benhadji, K. A., Massard, Christophe
Yayımlandı Invest New Drugs (2019)

OS2.2 Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial

Yazar: Dietrich, P, Wick, W, Hilf, N, Frenzel, K, Gouttefangeas, C, Platten, M, thor Straten, P, Lassen, U, Rodon, J, Bukur, V, Admon, A, van der Burg, S H, von Deimling, A, Kroep, J R, Martinez-Ricarte, F, Okada, H, Ottensmeier, C H, Ponsati, B, Poulsen, H S, Stevanovic, S, Tabatabai, G, Rammensee, H, Sahin, U, Singh-Jasuja, H
Yayımlandı Neuro Oncol (2018)

Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children

Yazar: Drilon, A., Laetsch, T.W., Kummar, S., DuBois, S.G., Lassen, U.N., Demetri, G.D., Nathenson, M., Doebele, R.C., Farago, A.F., Pappo, A.S., Turpin, B., Dowlati, A., Brose, M.S., Mascarenhas, L., Federman, N., Berlin, J., El-Deiry, W.S., Baik, C., Deeken, J., Boni, V., Nagasubramanian, R., Taylor, M., Rudzinski, E.R., Meric-Bernstam, F., Sohal, D.P.S., Ma, P.C., Raez, L.E., Hechtman, J.F., Benayed, R., Ladanyi, M., Tuch, B.B., Ebata, K., Cruickshank, S., Ku, N.C., Cox, M.C., Hawkins, D.S., Hong, D.S., Hyman, D.M.
Yayımlandı N Engl J Med (2018)